158 related articles for article (PubMed ID: 24598183)
21. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Byrne JL; Stainer C; Hyde H; Miflin G; Haynes AP; Bessell EM; Russell NH
Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
[TBL] [Abstract][Full Text] [Related]
22. Current insights into ocular graft-versus-host disease.
Riemens A; te Boome L; Imhof S; Kuball J; Rothova A
Curr Opin Ophthalmol; 2010 Nov; 21(6):485-94. PubMed ID: 20729735
[TBL] [Abstract][Full Text] [Related]
23. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-host disease: emerging concepts in prevention and therapy.
Dean RM; Bishop MR
Curr Hematol Rep; 2003 Jul; 2(4):287-94. PubMed ID: 12901325
[TBL] [Abstract][Full Text] [Related]
25. Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease.
Michael M; Shimoni A; Nagler A
Isr Med Assoc J; 2013 Jan; 15(1):44-50. PubMed ID: 23484241
[TBL] [Abstract][Full Text] [Related]
26. Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
McNeil C
J Natl Cancer Inst; 2013 Jul; 105(13):922-3. PubMed ID: 23781000
[No Abstract] [Full Text] [Related]
27. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Greinix HT; Worel N; Knobler R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
[No Abstract] [Full Text] [Related]
28. [GVHD and GVL].
Teshima T
Rinsho Ketsueki; 2009 Oct; 50(10):1407-19. PubMed ID: 19915349
[No Abstract] [Full Text] [Related]
29. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
Woltz P; Castro K; Park BJ
Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
[TBL] [Abstract][Full Text] [Related]
30. Steroid refractory psoriasiform cutaneous graft versus host disease successfully treated by extracorporeal photopheresis: a case report.
Sirinoglu Demiriz I; Tekgunduz E; Tetik A; Kayikci O; Altuntas F
Transfus Apher Sci; 2013 Feb; 48(1):109-11. PubMed ID: 23017807
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
33. Very late appearance of acute graft-versus-host disease after tapering immunosuppression.
Wollina U; Sayer HG; Wollina K; Graefe T
J Dermatol; 2001 Dec; 28(12):734-6. PubMed ID: 11804070
[TBL] [Abstract][Full Text] [Related]
34. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
35. Chronic graft-vs-host disease.
Bhushan V; Collins RH
JAMA; 2003 Nov; 290(19):2599-603. PubMed ID: 14625337
[No Abstract] [Full Text] [Related]
36. Is there an effective therapy for chronic graft-versus-host disease?
Schiller G; Gale RP
Bone Marrow Transplant; 1993 Mar; 11(3):189-92. PubMed ID: 8467281
[No Abstract] [Full Text] [Related]
37. Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors.
Jedlickova Z; Burlakova I; Bug G; Baurmann H; Schwerdtfeger R; Schleuning M
Biol Blood Marrow Transplant; 2011 May; 17(5):657-63. PubMed ID: 20696263
[TBL] [Abstract][Full Text] [Related]
38. The protection and therapy effects of bortezomib in murine acute graft-versus-host disease.
Li Z; Wu Q; Yan Z; Li D; Lu G; Mou W; Wu S; Pan X; Lu Q; Xu K
Transplant Proc; 2013; 45(6):2527-35. PubMed ID: 23953575
[TBL] [Abstract][Full Text] [Related]
39. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
40. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
